HY-100575-100mg
|
MedChemexpress LLC
|
Acriflavine [CAS 8048-52-0]
|
|
Cancer-programmed cell death
|
|
HY-103466-1mg
|
MedChemexpress LLC
|
FM4-64 [CAS 162112-35-8]
|
|
|
|
HY-103466-5mg
|
MedChemexpress LLC
|
FM4-64 [CAS 162112-35-8]
|
|
|
|
HY-113303-10mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
HY-113303-100mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
HY-113303-25mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
HY-113303-5mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
HY-113303-50mg
|
MedChemexpress LLC
|
FAPy-adenine [CAS 5122-36-1]
|
|
Cancer-programmed cell death
|
|
HY-117427-10mg
|
MedChemexpress LLC
|
D5D-IN-326 [CAS 1236767-85-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-117427-100mg
|
MedChemexpress LLC
|
D5D-IN-326 [CAS 1236767-85-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-117427-5mg
|
MedChemexpress LLC
|
D5D-IN-326 [CAS 1236767-85-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-117427-50mg
|
MedChemexpress LLC
|
D5D-IN-326 [CAS 1236767-85-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-121107-500mg
|
MedChemexpress LLC
|
Chrysene [CAS 218-01-9]
|
|
Cancer-programmed cell death
|
|
HY-122704A-10mg
|
MedChemexpress LLC
|
Surfen (dihydrochloride) [CAS 5424-37-3]
|
|
COVID-19-anti-virus
|
|
HY-122704A-100mg
|
MedChemexpress LLC
|
Surfen (dihydrochloride) [CAS 5424-37-3]
|
|
COVID-19-anti-virus
|
|
HY-122704A-25mg
|
MedChemexpress LLC
|
Surfen (dihydrochloride) [CAS 5424-37-3]
|
|
COVID-19-anti-virus
|
|
HY-122704A-5mg
|
MedChemexpress LLC
|
Surfen (dihydrochloride) [CAS 5424-37-3]
|
|
COVID-19-anti-virus
|
|
HY-122704A-50mg
|
MedChemexpress LLC
|
Surfen (dihydrochloride) [CAS 5424-37-3]
|
|
COVID-19-anti-virus
|
|
HY-128612-5g
|
MedChemexpress LLC
|
Methylnitronitrosoguanidine [CAS 70-25-7]
|
|
Cancer-programmed cell death
|
|
HY-131688-1mg
|
MedChemexpress LLC
|
2-Chlorohexadecanoic acid [CAS 19117-92-1]
|
|
COVID-19-immunoregulation
|
|
HY-132142-10mg
|
MedChemexpress LLC
|
5-Propargylamino-dCTP [CAS 115899-39-3]
|
|
Cancer-programmed cell death
|
|
HY-132142-5mg
|
MedChemexpress LLC
|
5-Propargylamino-dCTP [CAS 115899-39-3]
|
|
Cancer-programmed cell death
|
|
HY-137843-10mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
HY-137843-100mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|
HY-137843-25mg
|
MedChemexpress LLC
|
NSC 80467 [CAS 101982-51-8]
|
|
Cancer-programmed cell death
|
|